Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
6.28
+0.08 (1.29%)
Apr 29, 2025, 2:45 PM CST

Jinhe Biotechnology CO., LTD. Company Description

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera.

It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD.

was founded in 1990 and is based in Dalian, China.

Jinhe Biotechnology CO., LTD.
Country China
Founded 1990
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,316
CEO Changxian Xie

Contact Details

Address:
1-7-2 Building 27
Dalian, Liaoning Province 116023
China
Website jinhe.com.cn

Stock Details

Ticker Symbol 002688
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001HK7
SIC Code 2834

Key Executives

Name Position
Changxian Xie GM and Director
You Shan Niu Financial Director
Zhi Jun Wang Deputy GM and Director
Yueqing Wang Deputy GM and Non-Independent Director
Manman Lu Board Secretary and Director
Zhi Sheng Wang Deputy General Manager
Ying Chun Liu Deputy General Manager
Yingzhen Guan Deputy General Manager
Lihang Zhou Chief Accounting Officer